1. Optimal duration of adjuvant bisphosphonate treatment for high‐risk early breast cancer: Results from a SUCCESS trial. Issue 3 (2nd January 2022) Authors: Lu, Mingbei; Ren, Beibei; Rao, Lingyan Journal: Thoracic cancer Issue: Volume 13:Issue 3(2022) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗